₹7.3
▲ +0.04 +0.55%
17 Jul 2026
NSE Listed
Lasa Supergenerics Ltd. (LASA)
Volume: 6,306Avg Vol 1W: 18,165.4Avg Vol 1M: 22,872.7552W Range:₹5.67₹14.08
Key Ratios
Checked 18h agoMarket Cap₹37 Cr
Current Price₹7.3
Previous Close₹7.26
High / Low (52w)₹14.08 / ₹5.67
Volume6,306
Avg Vol (1W)18,165.4
Avg Vol (1M)22,872.75
Stock P/E—
Book Value₹9.9
Dividend Yield—
ROE—
ROA—
Revenue (TTM)₹147 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹-0.83
P/B0.73
Debt / Equity—
50 DMA₹7.65
200 DMA₹8.77
Day change+0.55%
Price Chart
₹7.3▼ 38.66% · 1Y
2025-07-162026-07-15
20-day avg volume: 23K shares
Pros
- Stock trades below its book value.
Cons
- Revenue fell 17% YoY.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹31 Cr | ₹39 Cr | ₹33 Cr | ₹39 Cr | ₹20 Cr | ₹3 Cr | ₹2 Cr | ₹0 Cr |
| EBITDA | ₹-1 Cr | ₹0 Cr | ₹-2 Cr | ₹2 Cr | ₹-2 Cr | ₹-6 Cr | ₹-2 Cr | ₹-3 Cr |
| Net Profit | ₹-3 Cr | ₹-3 Cr | ₹5 Cr | ₹-14 Cr | ₹-21 Cr | ₹-6 Cr | ₹-3 Cr | ₹-4 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹247 Cr | ₹170 Cr | ₹167 Cr | ₹202 Cr | ₹137 Cr | ₹131 Cr | ₹104 Cr | ₹147 Cr |
| EBITDA | ₹27 Cr | ₹-8 Cr | ₹13 Cr | ₹31 Cr | ₹2 Cr | ₹-18 Cr | ₹-8 Cr | ₹-1 Cr |
| Net Profit | ₹12 Cr | ₹-12 Cr | ₹4 Cr | ₹23 Cr | ₹-5 Cr | ₹-39 Cr | ₹-22 Cr | ₹-15 Cr |
| EPS | 5.43 | -5.26 | 0.89 | 5.6 | -1.06 | -7.71 | -4.34 | -2.95 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹287 Cr | ₹258 Cr | ₹232 Cr | ₹208 Cr | ₹209 Cr | ₹164 Cr | ₹151 Cr | ₹102 Cr |
| Total Liabilities | ₹169 Cr | ₹153 Cr | ₹91 Cr | ₹49 Cr | ₹51 Cr | ₹46 Cr | ₹54 Cr | ₹18 Cr |
| Equity | ₹117 Cr | ₹105 Cr | ₹141 Cr | ₹159 Cr | ₹158 Cr | ₹118 Cr | ₹97 Cr | ₹84 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹41 Cr | ₹12 Cr | ₹-17 Cr | ₹2 Cr | ₹-3 Cr |
| Investing | ₹-4 Cr | ₹-3 Cr | ₹11 Cr | ₹0 Cr | ₹8 Cr |
| Financing | ₹-36 Cr | ₹0 Cr | ₹-4 Cr | ₹-2 Cr | ₹-6 Cr |
| Free Cash Flow | ₹41 Cr | ₹12 Cr | ₹-17 Cr | ₹2 Cr | ₹-3 Cr |
Shareholding
Promoter 53.65% Institutions 0% Public 46.35%
Efficiency & Working Capital
ROCE0%
Interest Coverage-0.4
Dividend Payout—
Debtor Days4 d
Inventory Days63 d
Payable Days26 d
Cash Conversion Cycle40 d
Working Capital Days67 d
Shareholding Details
As of 2026-03-31
Promoter53.7%
FII0%
DII0%
Institutions0%
Public46.3%
Promoter Pledge20.7%
No. of Shareholders27,702
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% |
| FIIs | 0% | 0% | 0% | 0.1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 46.3% | 46.3% | 46.3% | 46.2% | 46.3% | 46.3% | 46.3% | 46.3% | 46.3% | 46.3% | 46.3% | 46.3% |
| Promoter Pledge | 20.7% | 20.7% | 20.7% | 20.7% | 20.7% | 20.7% | 20.7% | 20.7% | 20.7% | 20.7% | 20.7% | 20.7% |
| No. of Shareholders | 28,031 | 27,770 | 27,161 | 27,615 | 27,217 | 27,969 | 27,272 | 27,188 | 27,188 | 28,656 | 28,120 | 27,702 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Omkar Pravin Herlekar | Shareholding of Promoter and Promoter Group | 53.7% | 2.69 Cr |
| Mahendra Girdharilal Wadhwani | Public Shareholding | 1% | 5,01,013 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Omkar Pravin Herlekar | 55,53,649 | 20.7% | 2026-03-31 |
| Mahendra Girdharilal Wadhwani | 0 | 0% | 2026-03-31 |
| Omkar Pravin Herlekar | 55,53,649 | 20.7% | 2025-12-31 |
| Mahendra Girdharilal Wadhwani | 0 | 0% | 2025-12-31 |
| Omkar Pravin Herlekar | 55,53,649 | 20.7% | 2025-09-30 |
| Mahendra Girdharilal Wadhwani | 0 | 0% | 2025-09-30 |
| Omkar Pravin Herlekar | 55,53,649 | 20.7% | 2025-06-30 |
| Omkar Pravin Herlekar | 55,53,649 | 20.7% | 2025-03-31 |
| Omkar Pravin Herleker | 55,53,649 | 20.7% | 2024-12-31 |
| Bnp Enterprises | 0 | 0% | 2024-12-31 |
| Omkar Pravin Herleker | 55,53,649 | 20.7% | 2024-09-30 |
| BNP Enterprises | 0 | 0% | 2024-09-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Omkar P Herlekar | Chairman / Executive Director / M D / Promoter | 2025 |
| Prathamesh Chalke | E D & Wholetime Director | 2025 |
| Ketan Bhau Songal | Independent Non Exe. Director | 2025 |
| Pravin Gadalya Lachake | Independent Non Exe. Director | 2025 |
| Yogesh Hari Ughada | Independent Non Exe. Director | 2025 |
| Rekha Hemant Wakh | Independent Non Exe. Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Active Pharmaceutical Ingredients | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 1,000 | 50 | 50 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2024 | 0 | 0 | 0 | 2 | 0 | 2 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 1 | 0 | 1 |
Insider / Designated-Person Trades
6 recent disclosure(s)
Vineeta Hitesh WadhwaniDisposal · 58,500
Vineeta Hitesh WadhwaniAcquisition · 1,71,428
Omkar Pravin HerlekarAcquisition · 90,71,429
Shivanand Gajanan HegdeAcquisition · 1,85,714
OMKAR PRAVIN HERLEKARInvoke · 7,00,343
OMKAR PRAVIN HERLEKARInvoke · 21,59,879
Company Information
🌐 www.lasalabs.com ↗
📍 C-105 MIDC, Mahad, Raigad, Maharashtra, 402301
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search